Literature DB >> 32506133

The application of ubiquitin ligases in the PROTAC drug design.

Yilin Chen1, Jianping Jin1,2.   

Abstract

Protein ubiquitylation plays important roles in many biological activities. Protein ubiquitylation is a unique process that is mainly controlled by ubiquitin ligases. The ubiquitin-proteasome system (UPS) is the main process to degrade short-lived and unwanted proteins in eukaryotes. Many components in the UPS are attractive drug targets. Recent studies indicated that ubiquitin ligases can be employed as tools in proteolysis-targeting chimeras (PROTACs) for drug discovery. In this review article, we will discuss the recent progress of the application of ubiquitin ligases in the PROTAC drug design. We will also discuss advantages and existing problems of PROTACs. Moreover, we will propose a few principles for selecting ubiquitin ligases in PROTAC applications.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  PROTACs; drug discovery; protein degradation; ubiquitin ligase

Mesh:

Substances:

Year:  2020        PMID: 32506133     DOI: 10.1093/abbs/gmaa053

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  3 in total

Review 1.  Targeting Oncoproteins for Degradation by Small Molecule-Based Proteolysis-Targeting Chimeras (PROTACs) in Sex Hormone-Dependent Cancers.

Authors:  Li Liu; Lihong Shi; Zhaodi Wang; Jun Zeng; Yue Wang; Hongtao Xiao; Yongxia Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-18       Impact factor: 5.555

Review 2.  Small-Molecule PROTACs for Cancer Immunotherapy.

Authors:  Zefan Liu; Yajun Zhang; Yucheng Xiang; Xin Kang
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

Review 3.  PROTACs: The Future of Leukemia Therapeutics.

Authors:  Zubair Anwar; Muhammad Shahzad Ali; Antonio Galvano; Alessandro Perez; Maria La Mantia; Ihtisham Bukhari; Bartlomiej Swiatczak
Journal:  Front Cell Dev Biol       Date:  2022-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.